- Talanx anticipates a group net income of €1.98 billion for the fiscal year 2024, based on preliminary figures.
- The primary insurance revenue increased to €48.1 billion in 2024.
- The expected return on equity for 2024 stands at 17.8%.
- Talanx plans to increase the dividend to €4.00 per share by 2027.
- The Group has confirmed its earnings target of over €2.1 billion for 2025, a figure revised upwards in November 2024.
- Talanx aims to grow its net income to exceed €2.5 billion by 2027.
- Analyst ratings include 3 buys, 5 holds, and 2 sells.
“`
A look at Talanx Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 5 | |
| Resilience | 4 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 4.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts have assessed Talanx using Smartkarma Smart Scores, with a higher score indicating a more positive outlook for the company. Talanx received a solid overall outlook, with a value score of 3, dividend score of 4, growth score of 5, resilience score of 4, and momentum score of 4. This suggests that Talanx is well-positioned in terms of potential growth and dividend payouts, showing strong resilience and momentum in the market.
Talanx AG, operating as a holding company in the insurance and financial services sector, offers a wide range of insurance products globally. With its positive Smart Scores across various factors, including growth and dividend, Talanx seems to have a promising long-term outlook, indicating a potentially strong performance in the foreseeable future.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
